Elicio Therapeutics (ELTX) Long-Term Investments (2020 - 2023)
Elicio Therapeutics posted quarterly Long-Term Investments of $150000.0 for Q1 2023, down 79.51% year-on-year from $732000.0 in Q1 2022, and down 82.84% on a QoQ basis from $874000.0 in Q4 2022.
Elicio Therapeutics (ELTX) has 4 years of Long-Term Investments data on file, last reported at $150000.0 in Q1 2023.
- For the quarter ending Q1 2023, Long-Term Investments fell 79.51% year-over-year to $150000.0; the trailing twelve-month figure through Mar 2023 stood at $150000.0 (down 79.51% YoY), and the FY2022 full-year result was $874000.0, up 20.89% from the prior year.
- Long-Term Investments for Q1 2023 stood at $150000.0, down from $874000.0 in the prior quarter.
- Across five years, Long-Term Investments topped out at $877000.0 in Q1 2021 and bottomed at $150000.0 in Q1 2023.
- The 4-year median for Long-Term Investments is $852500.0 (2021), against an average of $762200.0.
- The widest annual swing landed in 2022, when Long-Term Investments rose 20.89%; it then plunged 79.51% in 2023.
- A 4-year view of Long-Term Investments shows it stood at $822000.0 in 2020, then decreased by 12.04% to $723000.0 in 2021, then gained by 20.89% to $874000.0 in 2022, then plunged by 82.84% to $150000.0 in 2023.
- The last three Long-Term Investments figures came in at $150000.0 (Q1 2023), $874000.0 (Q4 2022), and $874000.0 (Q3 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 505,194.89 |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 5.75 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 9.79 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 22.17 Mn |
| 10 | Elicio Therapeutics | 217.63 Mn | 202.68 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 150,000.00 |
| Dec 31, 2022 | 874,000.00 |
| Sep 30, 2022 | 874,000.00 |
| Jun 30, 2022 | 865,000.00 |
| Mar 31, 2022 | 732,000.00 |
| Dec 31, 2021 | 723,000.00 |
| Sep 30, 2021 | 862,000.00 |
| Jun 30, 2021 | 843,000.00 |
| Mar 31, 2021 | 877,000.00 |
| Dec 31, 2020 | 822,000.00 |